Skip to main content
John Sloan, MD, Hematology, Boston, MA, Boston Medical Center

JohnMSloanMD

Hematology • Boston, MA

Clotting Disorder, Hematologic Oncology

Associate Professor, Medicine, Boston University School of Medicine

Join to view full profile

Dr. Sloan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sloan's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2004
  • Yale School of Medicine
    Yale School of MedicineClass of 2001
  • Haverford College
    Haverford CollegeBS, Physics, With High Honors, 1992 - 1996

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2005 - 2024
  • CT State Medical License
    CT State Medical License 2004 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Evans Quality Improvement Award Boston University, 2013
  • Physician Scholar in International Health Johnson and Johnson, 2003
  • American Cancer Society Award American Cancer Society, 2001
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Heparin-Induced Thrombocytopenia and Thrombosis During High Dose Melphalan and Autologous Stem Cell Transplantation  
    Dina Brauneis, Vaishali Sanchorawala, J Mark Sloan, Shayna Sarosiek, Blood
  • Beyond Methotrexate: Treatment of Residual Disease in Primary Central Nervous System Lymphoma  
    Sloan JM, Hochberg E, Hochberg F, The American Journal of Hematology/Oncology, 1/1/2007
  • Contrast mechanisms for scanning tunneling microscopy of biological molecules  
    Sloan JM and Smith WF, Probe Microscopy, 1/1/1997
  • Join now to see all

Books/Book Chapters

  • ACP Medicine 
    Chapter: Approach to the patient with benign hematologic disorders. 
    Sloan JM, Seldin DC2013
  • Multiple Myeloma: Pursuing the Plasma Cell 
    Chapter: Anemia and Erythropoeitic Growth factors in Multiple Myeloma. 
    Sloan JM, Raje NEditors: Sagar Lonial.Humana Press2008

Abstracts/Posters

  • Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results o...
    John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive Events
    John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease
    John Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • "Guest Speaker" 
    Miami, FL - 1/10/2015
  • "Medical Marijuana in Oncology: Benefits and potential pitfalls." 
    6/18/2014
  • Join now to see all

Hospital Affiliations

Dr. John Sloan, Dr. John Sloan, MD, Dr. J Sloan, Dr. John M Sloan